Identification of p38 beta as a therapeutic target for the treatment of Sézary Syndrome

Cutaneous T-Cell Lymphomas (CTCL) represent a group of hematopoietic malignancies that home to the skin and have no known molecular basis for disease pathogenesis. Sézary syndrome (SS) is the leukemic variant of CTCL. Currently, CTCL is incurable, highlighting the need for new therapeutic modalities...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Invest Dermatol
Main Authors: Bliss-Moreau, Meghan, Coarfa, Cristian, Gunaratne, Preethi H, Guitart, Joan, Krett, Nancy L, Rosen, Steven T
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4289446/
https://ncbi.nlm.nih.gov/pubmed/25148579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2014.367
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados